Citadel Advisors
CLPT icon

Citadel Advisors’s ClearPoint Neuro CLPT Stock Holding History

Citadel Advisors’s Portfolio CLPT Stock Details CLPT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-43,364
Closed -$548K – 13117
2025
Q4 		$593K Sell
43,364
-43,128
-50% -$799K ﹤0.01% 8621
2025
Q3 		$1.88M Buy
86,492
+6,923
+9% +$81.6K ﹤0.01% 6186
2025
Q2 		$950K Buy
79,569
+67,360
+552% +$848K ﹤0.01% 7217
2025
Q1 		$145K Sell
12,209
-12,969
-52% -$202K ﹤0.01% 10927
2024
Q4 		$387K Sell
25,178
-60,736
-71% -$787K ﹤0.01% 9123
2024
Q3 		$963K Sell
85,914
-99,078
-54% -$949K ﹤0.01% 6943
2024
Q2 		$997K Buy
184,992
+110,216
+147% +$638K ﹤0.01% 6581
2024
Q1 		$508K Buy
74,776
+46,759
+167% +$327K ﹤0.01% 8363
2023
Q4 		$190K Sell
28,017
-58,191
-68% -$329K ﹤0.01% 10031
2023
Q3 		$432K Sell
86,208
-17,706
-17% -$105K ﹤0.01% 8391
2023
Q2 		$752K Buy
103,914
+29,976
+41% +$255K ﹤0.01% 7047
2023
Q1 		$624K Sell
73,938
-51,002
-41% -$447K ﹤0.01% 7839
2022
Q4 		$1.06M Buy
124,940
+98,165
+367% +$930K ﹤0.01% 6711
2022
Q3 		$277K Sell
26,775
-8,342
-24% -$110K ﹤0.01% 9742
2022
Q2 		$458K Buy
+35,117
New +$359K ﹤0.01% 8838
2022
Q1 		– Sell
-31,995
Closed -$291K – 13685
2021
Q4 		$359K Sell
31,995
-10,233
-24% -$153K ﹤0.01% 10503
2021
Q3 		$750K Buy
42,228
+1,728
+4% +$32.4K ﹤0.01% 8870
2021
Q2 		$773K Buy
+40,500
New +$783K ﹤0.01% 9032
2019
Q4 		– Sell
-10,268
Closed -$52K – 9168
2019
Q3 		$52K Buy
+10,268
New +$42.1K ﹤0.01% 8687

Other funds holding CLPT

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
MCO
MAK Capital One New York $679M AUM 29.02% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
LG
Lane Generational Dover, Massachusetts $126M AUM 53.89% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
SG Americas Securities
SG Americas Securities New York $92.9B AUM 36.98% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return

Citadel Advisors's CLPT Position: Q1 2026 in Review

Citadel Advisors sold out of ClearPoint Neuro (CLPT) in Q1 2026, closing a stake of 43,364 shares — an estimated $548K sold.

Citadel Advisors first reported a position in CLPT in Q3 2019 and held it in 19 quarters. The position peaked at $1.88M in Q3 2025. 118 funds tracked by Wall St. Rank hold CLPT as of Q1 2026.

  • Citadel Advisors reported no remaining ClearPoint Neuro position as of Q1 2026 after selling out during the quarter.
  • Citadel Advisors sold 43,364 ClearPoint Neuro shares in Q1 2026, an estimated $548K.
  • Citadel Advisors first reported a position in ClearPoint Neuro in Q3 2019 and held it in 19 quarters.
  • Citadel Advisors's ClearPoint Neuro position peaked at $1.88M in Q3 2025.
  • 118 funds tracked by Wall St. Rank held ClearPoint Neuro as of Q1 2026.

Based on Citadel Advisors's 13F filing for Q1 2026, filed 15 May 2026.